NCT06632158

Brief Summary

Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual control. The outcome measures are self-reported social problem-solving, self-efficacy, stress, depression, anxiety, attitudes towards seeking mental health, and knowledge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
268

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started May 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 6, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 1, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

October 6, 2024

Last Update Submit

April 28, 2025

Conditions

Keywords

Problem-Solving TherapyOnline AppMindBoba

Outcome Measures

Primary Outcomes (7)

  • Social problem-solving

    Social problem-solving will be measured using the Social Problem-Solving Inventory-Revised: Short Form (SPSI-R).The SPSI-R: Short Form is a 25-item multi-dimensional measure of social problem solving derived from a factor analysis of the original 70-item theory-driven Social Problem-Solving Inventory. In addition to a total score, it consists of five scales that measure two constructive dimensions (positive problem orientation, rational problem solving) and three dysfunctional dimensions (negative problem orientation, impulsivity/carelessness style, avoidance style).

    Baseline and 12 weeks

  • Self-Efficacy

    Self-efficacy will be measured using the Mental Health Self-Efficacy Scale (MHSES), a 6-item Likert-type single-factor scale measuring one's capability to perform behaviors related to mental health. The MHSES has demonstrated good internal reliability (alpha = .89) and is positively correlated with work, social adjustment, and emotional stability, and negatively correlated with measures of depression.

    Baseline and 12 weeks

  • Stress

    Stress will be assessed using the Depression Anxiety and Stress Scale-21 (DASS-21).128 The DAS-21 is a 21-item scale that measures three related negative states of depression, anxiety, and stress. It has shown strong internal reliability and moderate validity through confirmatory factor analysis,

    Baseline and 12 weeks

  • Anxiety

    Anxiety will be assessed using the Depression Anxiety and Stress Scale-21 (DASS-21).128 The DAS-21 is a 21-item scale that measures three related negative states of depression, anxiety, and stress. It has shown strong internal reliability and moderate validity through confirmatory factor analysis,

    Baseline and 12 weeks

  • Depression

    Depression will be assessed using the Depression Anxiety and Stress Scale-21 (DASS-21).128 The DAS-21 is a 21-item scale that measures three related negative states of depression, anxiety, and stress. It has shown strong internal reliability and moderate validity through confirmatory factor analysis,

    Baseline and 12 weeks

  • Attitudes towards seeking mental help

    Attitudes towards seeking mental help will be assessed using the Mental Help Seeking Attitudes Scale (MHSAS) and the Perceived Devaluation and Discrimination Scale (PDD). The MHSAS a 9-item scale that measures participants' overall attitudes (positive or negative) towards seeking help from a mental health expert. The PDD is a 12-item scale that assesses stigma around mental health. Both the MHSAS and the PDD have demonstrated good internal consistency and test-retest reliability. The PDD has been used translated into Chinese.138 In addition to these two scales, the investigators will develop items to assess participants' attitudes towards using mHealth mental health applications specifically.

    Baseline and 12 weeks

  • Knowledge

    Knowledge will be measured using a multiple-choice survey that the project developed to determine the extent to which participants understand basic information delivered in the program around Problem-Solving Therapy skills and content.

    12 weeks

Secondary Outcomes (3)

  • Loss of face

    Baseline and 12 weeks

  • Motivation to engage with the intervention

    12 weeks

  • Usability, content utility and validity, user satisfaction, and cultural relevance

    12 weeks

Study Arms (3)

MindBoba

EXPERIMENTAL

Participants will be given access to the MindBoba app for 12 weeks.

Behavioral: MindBoba

Mindshift CBT

ACTIVE COMPARATOR

Participants will be given access to the Mindshift CBT app for 12 weeks.

Behavioral: Mindshift CBT

Business-as-Usual

NO INTERVENTION

Interventions

MindBobaBEHAVIORAL

MindBoba is a smartphone app that uses strategies based on Problem-Solving Therapy to help decrease stress and anxiety, and teach new skills.

MindBoba
Mindshift CBTBEHAVIORAL

MindShift® CBT uses strategies based on Cognitive Behavioural Therapy (CBT) to help participants learn to relax and be mindful, develop more effective ways of thinking, and use active steps to take charge of their anxiety.

Mindshift CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chinese American
  • ability to understand English, Mandarin, or Cantonese
  • has access to a mobile device running Android or iOS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IrisEd dba Trifoia

Eugene, Oregon, 97401, United States

Location

MeSH Terms

Conditions

BehaviorAnxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-arm design comparing the new intervention (MindBoba) to an active control (Mindshift CBT) and business-as-usual.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Scientist

Study Record Dates

First Submitted

October 6, 2024

First Posted

October 8, 2024

Study Start

May 1, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

May 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Once the final results of the project are accepted for publication all de-identified final research data and associated codebooks will be made accessible to interested researchers upon request to the PI and archived with the Inter-university Consortium for Political and Social Research (ICPSR).

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the final report of the grant is submitted and associated publications are accepted we will make the de-identified final research data and associated codebooks available within 6 months.

Locations